Eton Pharmaceuticals, Inc.
ETON
$17.28
-$0.18-1.03%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.00% | -93.83% | 73.49% | 208.29% | -166.70% |
| Total Depreciation and Amortization | 260.22% | 332.91% | 9.23% | 45.55% | 62.21% |
| Total Amortization of Deferred Charges | 32.20% | 1,076.00% | 4,386.96% | -2.50% | -16.90% |
| Total Other Non-Cash Items | 299.76% | 181.17% | 4.28% | -1.10% | 4.71% |
| Change in Net Operating Assets | 96.91% | 99.86% | -254.86% | 161.91% | 106.86% |
| Cash from Operations | 534.18% | 184.51% | -297.67% | 238.14% | -82.33% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -947.74% | -- | -- |
| Cash from Investing | -- | -- | -4,820.26% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | 0.00% | 0.00% |
| Issuance of Common Stock | -100.00% | 5,528.57% | 8,980.22% | -100.00% | 20.71% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 100.00% | 204.23% | 11,519.05% | -4.34% | 11.84% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 666.03% | 152.48% | -680.79% | 409.33% | -84.85% |